Could the Bendigo and Adelaide Bank (ASX:BEN) share price hit $11 by the end of 2021?

Is this bank share in the buy zone?

The Bendigo and Adelaide Bank Ltd (ASX: BEN) share price has been underperforming in 2021.

Since the start of the year, the regional bank's shares have edged almost 1% lower to $9.38.

As a comparison, the Commonwealth Bank of Australia (ASX: CBA) share price is up 25% and the National Australia Bank Ltd (ASX: NAB) share price is up 26% over the same period.

Confident male executive dressed in a dark blue suit leans against a doorway with his arms crossed in the corporate office

Image source: Getty Images

Could the Bendigo and Adelaide Bank share price hit $11 by the end of the year?

While the Bendigo and Adelaide Bank share price has been underperforming so far this year, one leading broker sees potential for it to rebound strongly.

According to a recent note out Macquarie Group Ltd (ASX: MQG), its analysts currently have an outperform rating and $11.00 price target on the bank's shares.

Based on the current Bendigo and Adelaide Bank share price, this implies potential upside of 17% for investors.

In addition, the broker has pencilled in a fully franked 55 cents per share in FY 2022. This represents a yield of 5.9%, stretching the total return on offer to approximately 23%.

What did the broker say?

Macquarie is positive on Bendigo and Adelaide Bank due to its growth strategy, which it feels is delivering results. And while it suspects competition may continue to weigh on margins, it appears optimistic that its strong balance sheet momentum will drive revenue growth.

All in all, the broker appears to see potential for the bank's shares to be trading at $11.00 come the end of the year. Though, given its underperformance, it will no doubt need a catalyst.

That could potentially come at its annual general meeting next month if the bank releases a trading update at the event. Though, time will tell if that is the case.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Bendigo and Adelaide Bank Limited and Macquarie Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Businessman at his desk, looking seriously at information on his digital tablet.
ASX Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the local market today.

Read more »

Four miners discussing with each other next to mining machinery.
Broker Notes

Why are these 8 ASX rare earths companies rated a buy?

Technology is driving strong uptake of rare earths, which are in short supply.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a volatile, but successful, day for investors.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

Bell Potter has tipped these ASX small caps to almost double in value

Big things could lie ahead for these two very different companies.

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today.
Broker Notes

Austal, BHP, Westpac shares: Buy, sell, hold

One ASX share is forecast to jump 28% higher.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Morgans names 3 ASX shares to buy now

The broker is feeling bullish about these names. Let's find out why.

Read more »

Man with hand to his forehead looking at his laptop.
Broker Notes

Buy, hold, sell: Deep Yellow, PLS, Pro Medicus shares

Morgans has given its verdict on these shares. Here's how it rates them.

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
Opinions

CSL shares: I weighed up the bull and bear case, and here's my final verdict

The ASX biotech company has rebounded strongly from a multi-year low in June.

Read more »